609 related articles for article (PubMed ID: 28494905)
21. The effect of sugammadex on steroid hormones: A randomized clinical study.
Gunduz Gul G; Ozer AB; Demirel I; Aksu A; Erhan OL
J Clin Anesth; 2016 Nov; 34():62-7. PubMed ID: 27687347
[TBL] [Abstract][Full Text] [Related]
22. Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.
Wu X; Oerding H; Liu J; Vanacker B; Yao S; Dahl V; Xiong L; Claudius C; Yue Y; Huang Y; Abels E; Rietbergen H; Woo T
BMC Anesthesiol; 2014; 14():53. PubMed ID: 25187755
[TBL] [Abstract][Full Text] [Related]
23. Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.
Jones RK; Caldwell JE; Brull SJ; Soto RG
Anesthesiology; 2008 Nov; 109(5):816-24. PubMed ID: 18946293
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
[TBL] [Abstract][Full Text] [Related]
25. Residual neuromuscular blockade in a real life clinical setting: correlation with sugammadex or neostigmine administration.
Batistaki C; Tentes P; Deligiannidi P; Karakosta A; Florou P; Kostopanagiotou G
Minerva Anestesiol; 2016 May; 82(5):550-8. PubMed ID: 26394365
[TBL] [Abstract][Full Text] [Related]
26. Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns.
Bash LD; Black W; Turzhitsky V; Urman RD
Anesth Analg; 2021 Dec; 133(6):1437-1450. PubMed ID: 34784330
[TBL] [Abstract][Full Text] [Related]
27. Intraoperative reversal of neuromuscular block with sugammadex or neostigmine during extreme lateral interbody fusion, a novel technique for spine surgery.
Adamus M; Hrabalek L; Wanek T; Gabrhelik T; Zapletalova J
J Anesth; 2011 Oct; 25(5):716-20. PubMed ID: 21842171
[TBL] [Abstract][Full Text] [Related]
28. Sugammadex: A Review of Neuromuscular Blockade Reversal.
Keating GM
Drugs; 2016 Jul; 76(10):1041-52. PubMed ID: 27324403
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of sugammadex versus neostigmine on restoration of neuromuscular function in surgical patients with myasthenia gravis undergoing rocuronium-induced neuromuscular blockade: a systematic review protocol.
Yellott E; Badeaux J; Martin J; Schiavo JH
JBI Database System Rev Implement Rep; 2018 Oct; 16(10):1922-1928. PubMed ID: 30335038
[TBL] [Abstract][Full Text] [Related]
31. A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada.
Insinga RP; Joyal C; Goyette A; Galarneau A
BMC Anesthesiol; 2016 Nov; 16(1):114. PubMed ID: 27852231
[TBL] [Abstract][Full Text] [Related]
32. [Problem of neuromuscular block reversion: neostigmine and sugammadex].
Mizikov VM; Stamov VI; Deshko IuV; Ialich AIu
Anesteziol Reanimatol; 2010; (2):40-3. PubMed ID: 20524330
[TBL] [Abstract][Full Text] [Related]
33. Effect of variations in depth of neuromuscular blockade on rating of surgical conditions by surgeon and anesthesiologist in patients undergoing laparoscopic renal or prostatic surgery (BLISS trial): study protocol for a randomized controlled trial.
Boon M; Martini CH; Aarts LP; Bevers RF; Dahan A
Trials; 2013 Mar; 14():63. PubMed ID: 23452344
[TBL] [Abstract][Full Text] [Related]
34. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
35. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of sugammadex for antagonistic neuromuscular block in patients with radical resection of lung cancer under thoracoscope].
Ba YF; Liu YN; He SH; Li HM; Wang HR; Zhu JP; Xing WQ; Li CS
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(3):213-219. PubMed ID: 32008289
[No Abstract] [Full Text] [Related]
37. Comparison of recovery after sugammadex or neostigmine reversal of rocuronium in geriatric patients undergoing spine surgery: a randomized controlled trial.
Mraovic B; Timko NJ; Choma TJ
Croat Med J; 2021 Dec; 62(6):606-613. PubMed ID: 34981693
[TBL] [Abstract][Full Text] [Related]
38. Sugammadex: a cyclodextrin to reverse neuromuscular blockade in anaesthesia.
Donati F
Expert Opin Pharmacother; 2008 Jun; 9(8):1375-86. PubMed ID: 18473711
[TBL] [Abstract][Full Text] [Related]
39. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
[TBL] [Abstract][Full Text] [Related]
40. A Clinical and Budgetary Impact Analysis of Introducing Sugammadex for Routine Reversal of Neuromuscular Blockade in a Hypothetical Cohort in the US.
Jiang Y; Bash LD; Saager L
Adv Ther; 2021 May; 38(5):2689-2708. PubMed ID: 33871823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
